Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the Pancreas
Authors:
- Tsutomu FujiiTFTsutomu Fujii
- Yasuhiro KoderaYKYasuhiro Kodera
- Mitsuro KandaMKMitsuro Kanda
- Tevfik T. SahinTSTevfik T. Sahin
- Akiyuki KanzakiAKAkiyuki Kanzaki
- Suguru YamadaSYSuguru Yamada
- Hiroyuki SugimotoHSHiroyuki Sugimoto
- Shuji NomotoSNShuji Nomoto
- Shin TakedaSTShin Takeda
- Satoshi MoritaSMSatoshi Morita
- Akimasa NakaoANAkimasa Nakao
- 1 January 2011
- journal article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 40 (1) , 3-9
Abstract
The aim of this study was to determine the prognostic factors and assess the impact of excessive operative blood loss (OBL) on survival after pancreatectomy for invasive ductal adenocarcinoma. From the retrospective analysis, 271 patients were eligible for evaluation. Overall survival was assessed to clarify the prognostic determinants, including patient characteristics, perioperative factors, and tumor characteristics. The overall survival was significantly affected by the amount of OBL. The median survival times were 26.0, 15.3, and 8.7 months for OBL less than 1000, 1000 to 2000, and greater than 2000 mL, respectively (2000 mL, P < 0.0001). Operative blood loss greater than 2000 mL remained an independent prognostic factor in multivariate analysis (P = 0.003; hazards ratio, 2.55). Operative blood loss of 2010 mL was found to be an appropriate cutoff level to predict early mortality within 6 months after resection (sensitivity, 0.660; specificity, 0.739). Male sex, year of resection, and plexus invasion were independently associated with OBL greater than 2000 mL. Excessive OBL was found to be a prognostic determinant of survival after surgery for pancreatic cancer. Operative blood loss can be used to stratify the risk for pancreatic cancer mortality. Successful curative resection with limited blood loss can contribute to improved survival.Keywords
This publication has 29 references indexed in Scilit:
- The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic CancerJournal of Gastrointestinal Surgery, 2009
- Improved Survival Following Pancreaticoduodenectomy to Treat Adenocarcinoma of the Pancreas2008
- Prognostic factors for long-term survival in patients with locally invasive pancreatic cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic AdenocarcinomaAnnals of Surgery, 2007
- A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancerSurgery, 2004
- Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinomaBritish Journal of Surgery, 2004
- Prognostic Factors Following Curative Resection for Pancreatic AdenocarcinomaAnnals of Surgery, 2003
- Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicatorsJournal of Gastrointestinal Surgery, 2000
- Clinical Significance of Carcinoma Invasion of the Extrapancreatic Nerve Plexus in Pancreatic CancerPancreas, 1996
- Clinical significance of portal invasion by pancreatic head carcinomaSurgery, 1995